Trial
NCT01758588
Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
Merck Sharp & Dohme LLC
Condition
Myelofibrosis
Intervention
Peginterferon alfa-2a
Why stopped
This study was suspended due to insufficient subject accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-24